TNFRSF11A and endometrial cancer: RANK/RANKL expression was significantly elevated in endometrial cancer tissue of higher stage, i.e. deeper myometrial invasion, LN and vascular involvement, and showed decreased progression-free survival and overall survival (5 fold higher risk of death) [59, 60, 68].